Development of effective immunotherapy for triple negative breast cancer by WEE1 kinase inhibition

被引：0
|
作者：
Choi, Mi Ran [1 ]
Xie, Ping [1 ]
Tang, Hui [1 ]
Fan, Jie [1 ]
Ahn, Ji Hae [1 ]
Orpano, Rachel [1 ]
Zhang, Bin [1 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of cisplatin and the Wee1 inhibitor adavosertib in metastatic triple-negative breast cancer (mTNBC)
    Keenan, Tanya E.
    Tan-Wasielewski, Zhenying
    Trippa, Lorenzo
    Kochupurakkal, Bose
    Guerriero, Jennifer L.
    Tahara, Rie K.
    Winship, Grace
    Osmani, Wafa
    Andrews, Chelsea
    Conway, Jake R.
    He, Meng X.
    Pastorello, Ricardo
    Tracy, Adam
    Godin, Robert E.
    Overmoyer, Beth A.
    Winer, Eric P.
    Mittendorf, Elizabeth A.
    Shapiro, Geoffrey I.
    Van Allen, Eliezer M.
    Tolaney, Sara M.
    CANCER RESEARCH, 2020, 80 (04)
  • [22] Regulation of Wee1 kinase in response to protein synthesis inhibition
    Suda, M
    Yamada, S
    Toda, T
    Miyakawa, T
    Hirata, D
    FEBS LETTERS, 2000, 486 (03): : 305 - 309
  • [23] Loss of WEE1 kinase expression in gastric cancer
    Shah, M
    Choudry, B
    Gray, S
    Greenwood, D
    Martin, IG
    Dixon, MF
    Quirke, P
    Grabsch, H
    JOURNAL OF PATHOLOGY, 2002, 198 : 33A - 33A
  • [24] HDAC inhibition potentiates immunotherapy in triple negative breast cancer
    Terranova-Barberio, Manuela
    Thomas, Scott
    Ali, Niwa
    Pawlowska, Nela
    Park, Jeenah
    Krings, Gregor
    Rosenblum, Michael D.
    Budillon, Alfredo
    Munster, Pamela N.
    ONCOTARGET, 2017, 8 (69) : 114156 - 114172
  • [25] Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
    Teo, Zhi Ling
    O'Connor, Mark J.
    Versaci, Stephanie
    Clarke, Kylie A.
    Brown, Emmaline R.
    Percy, Luke W.
    Kuykhoven, Keilly
    Mintoff, Christopher P.
    Savas, Peter
    Virassamy, Balaji
    Luen, Stephen J.
    Byrne, Ann
    Sant, Sneha
    Lindeman, Geoffrey J.
    Darcy, Phillip K.
    Loi, Sherene
    NPJ BREAST CANCER, 2023, 9 (01)
  • [26] Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
    Zhi Ling Teo
    Mark J. O’Connor
    Stephanie Versaci
    Kylie A. Clarke
    Emmaline R. Brown
    Luke W. Percy
    Keilly Kuykhoven
    Christopher P. Mintoff
    Peter Savas
    Balaji Virassamy
    Stephen J. Luen
    Ann Byrne
    Sneha Sant
    Geoffrey J. Lindeman
    Phillip K. Darcy
    Sherene Loi
    npj Breast Cancer, 9
  • [27] WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy
    Sun, Lillian
    Moore, Ellen
    Berman, Rose
    Clavijo, Paul E.
    Saleh, Anthony
    Chen, Zhong
    Van Waes, Carter
    Davies, John
    Friedman, Jay
    Allen, Clint T.
    ONCOIMMUNOLOGY, 2018, 7 (10):
  • [28] Development of novel in situ immunotherapy for triple negative breast cancer
    Oba, Takaaki
    Ito, Fumito
    Ito, Kenichi
    CANCER SCIENCE, 2025, 116 : 27 - 27
  • [29] Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
    Fu, Siqing
    Wang, Yudong
    Keyomarsi, Khandan
    Meric-Bernstein, Funda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (09) : 741 - 751
  • [30] Molecular Pathways: Targeting the Protein Kinase Wee1 in Cancer
    Geenen, Jill J. J.
    Schellens, Jan H. M.
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4540 - 4544
12345